Cincinnati, OH, United States of America

Mary Gaskill-Shipley


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Mary Gaskill-Shipley: Innovator in Tumor Heterogeneity Measurement

Introduction

Mary Gaskill-Shipley is a notable inventor based in Cincinnati, OH (US). She has made significant contributions to the field of medical imaging, particularly in the characterization of intra-site tumor heterogeneity. Her innovative approach utilizes advanced magnetic resonance imaging (MRI) techniques to enhance the understanding of tumor behavior.

Latest Patents

Mary Gaskill-Shipley holds a patent for a method and system titled "Characterizing intra-site tumor heterogeneity." This patent outlines a comprehensive method for measuring intra-site heterogeneity in tumors using MRI. The process involves acquiring MR images, segmenting tumor sites, and dividing them into sub-regions. It further includes deriving image biomarkers, classifying each voxel or pixel into genotypes or molecular subtypes, and generating spatial information based on the distribution of these classifications. This innovative method aims to improve the assessment of tumor heterogeneity, which is crucial for effective treatment planning.

Career Highlights

Throughout her career, Mary has worked with esteemed institutions such as the University of Cincinnati and Children's Hospital Medical Center. Her work has been instrumental in advancing the field of medical imaging and tumor analysis.

Collaborations

Mary has collaborated with notable colleagues, including Jinghua Wang and Lili He. Their combined expertise has contributed to the development of innovative solutions in the medical imaging domain.

Conclusion

Mary Gaskill-Shipley is a pioneering inventor whose work in tumor heterogeneity measurement has the potential to transform cancer diagnostics and treatment. Her contributions to medical imaging continue to pave the way for advancements in understanding tumor behavior.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…